Drug Information
Drug Generic Name | SAXAGLIPTIN |
Drug Class | OTHER ANTIDIABETIC DRUGS |
Chapter | Endocrine System |
Indications: diabetes mellitus Cautions: Elderly; determine renal function before treatment and periodically thereafter; discontinue if symptoms of acute pancreatitis (persistent, severe abdominal pain). Contra-indications: history of serious hypersensitivity to dipeptidylpeptidase-4 inhibitors. Hepatic impairment: Use with caution in moderate impairment; avoid in severe impairment. Renal impairment: Reduce dose to 2.5 mg once daily in moderate to severe impairment; use with caution in severe impairment. Pregnancy: Avoid unless essential—toxicity in animal studies. Breast-feeding: Avoid—present in milk in animal studies. Side Effects: Vomiting, dyspepsia, gastritis; peripheral oedema; headache, dizziness, fatigue; upper respiratory tract infection, urinary tract infection, gastroenteritis, sinusitis, nasopharyngitis; hypoglycaemia, myalgia; less dyslipidaemia, hypertriglyceridaemia, erectile dysfunction, arthralgia, hypersensitivity reactions (including anaphylaxis); also reported rash.pancreatitis, Dose: ADULT over 18 years, 5 mg once daily |
|
Brand Name |
|